Anaplastic Ependymoma: Clinical Trials

7 trials for Anaplastic Ependymoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 terminated, 1 completed, 1 recruiting, 1 withdrawn. 7 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 27Terminated 4, Completed 1, Recruiting 1, Withdrawn 1
Phase 12Recruiting 1, Terminated 1

Follow Anaplastic Ependymoma: new trials by email Literature Review of Anaplastic Ependymoma trials Research Report on Anaplastic Ependymoma

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
LUTATHERAĀ® (Lutetium Lu 177 dotatate) - High Grade Glioma, Meningioma
Phase 1 / Phase 2RecruitingNationwide Children's Hospital652022-11-212026-11-16
Marizomib for Recurrent Low-Grade and Anaplastic Supratentorial, Infratentorial, and Spinal Cord Ependymoma
Marizomib - Anaplastic Ependymoma, Ependymoma
Phase 2TerminatedNational Cancer Institute (NCI)42020-01-222022-07-27
Imetelstat Sodium in Treating Younger Patients With Recurrent or Refractory Brain Tumors
imetelstat sodium - Anaplastic Astrocytoma, Anaplastic Ependymoma
Phase 2TerminatedPediatric Brain Tumor Consortium432013-03-012018-07-20
Phase I/II Trial of AXL1717 in the Treatment of Recurrent Malignant Astrocytomas
AXL1717 - Glioblastoma, Gliosarcoma
Phase 1 / Phase 2TerminatedRush University Medical Center102012-12-012023-05-22
Carboplatin and Bevacizumab for Recurrent Ependymoma
Carboplatin, Bevacizumab - Ependymoma, Anaplastic Ependymoma
Phase 2CompletedNational Cancer Institute (NCI)352011-04-272025-08-05
Ritonavir and Lopinavir in Treating Patients With Progressive or Recurrent High-Grade Glioma
ritonavir, lopinavir - Brain Tumor, Anaplastic Astrocytoma
Phase 2TerminatedCase Comprehensive Cancer Center192009-01-012013-06-10
Photodynamic Therapy in the Treatment of Malignant Intracranial Tumors
Photodynamic therapy using Photosan and LumaCareā„¢ Lamp Model LC-122M - Malignant Intracranial Tumors, Glioblastoma Multiforme
Phase 2WithdrawnNational Taiwan University Hospital52010-01-12

Narrower conditions

Ependymoma (7)  ·  Astrocytoma (4)  ·  Glioblastoma (4)  ·  Oligodendroglioma (4)  ·  Glioma (3)  ·  Gliosarcoma (3)  ·  Brain Neoplasms (2)  ·  Brain Stem Neoplasms (1)  ·  Central Nervous System Neoplasms (1)  ·  Diffuse Intrinsic Pontine Glioma (1)  ·  Disease Progression (1)  ·  Medulloblastoma (1)  ·  Meningioma (1)  ·  Neoplasms (1)  ·  Neoplasms, Germ Cell and Embryonal (1)

Broader conditions

Neoplasms by Histologic Type (7)  ·  Neoplasms, Glandular and Epithelial (7)  ·  Neoplasms, Nerve Tissue (7)  ·  Neoplasms, Neuroepithelial (7)  ·  Neuroectodermal Tumors (7)  ·  Neoplasms (6)  ·  Neoplasms, Germ Cell and Embryonal (6)  ·  Brain Diseases (4)  ·  Central Nervous System Diseases (4)  ·  Glioma (4)  ·  Neoplasms by Site (4)  ·  Nervous System Diseases (4)  ·  Nervous System Neoplasms (4)  ·  Central Nervous System Neoplasms (3)  ·  Brain Neoplasms (2)

Interventions

Bevacizumab (1)  ·  Carboplatin (1)  ·  GRN163L peptide (1)  ·  Lopinavir (1)  ·  Ritonavir (1)  ·  imetelstat (1)  ·  lutetium Lu 177 dotatate (1)  ·  marizomib (1)  ·  picropodophyllin (1)

Sponsors

National Cancer Institute (NCI) (2)  ·  Case Comprehensive Cancer Center (1)  ·  National Taiwan University Hospital (1)  ·  Nationwide Children's Hospital (1)  ·  Pediatric Brain Tumor Consortium (1)  ·  Rush University Medical Center (1)

Countries

United States (6)  ·  Taiwan (1)

Top investigators

David Peereboom, MD (1)  ·  Jui-Chang Tsai, M.D. Ph.D. (1)  ·  Kevin Camphausen, M.D. (1)  ·  Margot Lazow, MD (1)  ·  Mark R Gilbert, M.D. (1)  ·  Maryam Fouladi (1)  ·  Robert Aiken, MD (1)

NIH funding

U01CA081457 (1)